Publications

• Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.
  Transplantation
  06/23/2025 Authors: Gupta M; Schoettler ML; Orozco G; Brazauskas R; Bo-Subait S; Battiwalla M; Buchbinder D; Hamilton BK; Savani BN; Schoemans H
• An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy.
  Transplant Cell Ther
  06/11/2025 Authors: Schoettler ML; Gavriilaki E; Carreras E; Cho B-K; Dandoy CE; Ho VT; Jodele S; Moiseev I; Snchez-Ortega I; Srivastava A
• Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
  Br J Haematol Volume: 206 Page(s): 368 - 371
  01/01/2025 Authors: Frost EL; Chonat S; Williams KM; Aumann W; Stevenson J; Yin J; Schniederjan M; Arnold S; Schoettler ML
• Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.
  Transplant Cell Ther Volume: 30 Page(s): 1017.e1 - 1017.e12
  10/01/2024 Authors: Cheng G; Smith MA; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton B; Peterson A; Savani B; Schoemans H
• Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
  09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
• Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients-Beware Reliance on Schistocytes Alone.
  Transplant Cell Ther Volume: 30 Page(s): 818 - 820
  08/01/2024 Authors: Schoettler ML; Williams KM
• Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
  Br J Haematol Volume: 205 Page(s): 243 - 255
  07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
• Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.
  Blood Adv Volume: 8 Page(s): 1220 - 1233
  03/12/2024 Authors: Schoettler ML; Lehmann L; Kao P-C; Chen N; Jodele S; Chonat S; Williams KM; London WB; Duncan C; Dandoy C
• D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
  Am J Hematol Volume: 99 Page(s): 370 - 379
  03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
• Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
  03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
• Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes.
  Front Oncol Volume: 14 Page(s): 1415984
  01/01/2024 Authors: Smith MA; Cheng G; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton BK; Peterson A; Savani B; Schoemans H
• Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
  12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
• Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
  Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
  11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
• Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
  Pediatr Blood Cancer Volume: 70 Page(s): e30606
  10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML
• Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
  Blood Adv Volume: 7 Page(s): 4395 - 4399
  08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
• CLINICAL OUTCOMES OF CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
  Volume: 70 Page(s): S134 - S135
  06/01/2023 Authors: Saleem N; Graciaa S; McElfresh P; Arnold S; Schoettler M; Briones M; Chonat S
• DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
  Volume: 70 Page(s): S214 - S215
  06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
• Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
  Blood Adv Volume: 7 Page(s): 1784 - 1795
  05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
  Transplant Cell Ther Volume: 29 Page(s): 151 - 163
  03/01/2023 Authors: Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y
• Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
  Transplant Cell Ther Volume: 29 Page(s): 45.e1 - 45.e8
  01/01/2023 Authors: Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J
• Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality.
  Front Oncol Volume: 13 Page(s): 1232621
  01/01/2023 Authors: Schoettler ML; Dandoy CE; Harris A; Chan M; Tarquinio KM; Jodele S; Qayed M; Watkins B; Kamat P; Petrillo T
• Compassionate use narsoplimab to treat transplant associated thrombotic microangiopathy in a pediatric patient with multi-organ failure
  Volume: 57 Page(s): 350 - 350
  11/01/2022 Authors: Schoettler M; Bryson E; Deeb L; Qayed M; Watkins B; Chandrakasan S; Chonat S; Williams K
• Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
  Transplant Cell Ther Volume: 28 Page(s): 426 - 445
  08/01/2022 Authors: Cuvelier GDE; Schoettler M; Buxbaum NP; Pinal-Fernandez I; Schmalzing M; Distler JHW; Penack O; Santomasso BD; Zeiser R; Angstwurm K
• ABATACEPT FOR THE PREVENTION OF GVHD IN PEDIATRIC PATIENTS RECEIVING 7/8 HLA-MISMATCHED TRANSPLANT
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Betz K; Suessmuth Y; Gillespie S; Westbrook A; Williams K; Schoettler M; Langston A
• BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.
  Front Immunol Volume: 13 Page(s): 1064203
  01/01/2022 Authors: Schoettler ML; Bhatt H; Vasu S
• Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy.
  Curr Opin Hematol Volume: 28 Page(s): 408 - 416
  11/01/2021 Authors: Schoettler M; Chonat S; Williams K; Lehmann L
• A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
  Blood Adv Volume: 5 Page(s): 1 - 11
  01/12/2021 Authors: Dandoy CE; Rotz S; Alonso PB; Klunk A; Desmond C; Huber J; Ingraham H; Higham C; Dvorak CC; Duncan C
• DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor.
  Mod Pathol Volume: 33 Page(s): 1910 - 1921
  10/01/2020 Authors: Kamihara J; Paulson V; Breen MA; Laetsch TW; Rakheja D; Shulman DS; Schoettler ML; Clinton CM; Ward A; Reidy D
• Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
  Blood Adv Volume: 4 Page(s): 2536 - 2547
  06/09/2020 Authors: Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao P-C; Ma C; Duncan CN
• Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation.
  Bone Marrow Transplant Volume: 54 Page(s): 1158 - 1160
  07/01/2019 Authors: Schoettler M; Duncan C; Lehmann L; Furutani E; Subramaniam M; Margossian S
• Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
  Biol Blood Marrow Transplant Volume: 25 Page(s): e163 - e168
  05/01/2019 Authors: Schoettler M; Lehmann L; Li A; Ma C; Duncan C
• Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.
  Pediatr Transplant Volume: 23 Page(s): e13381
  05/01/2019 Authors: Schoettler M; Duncan C; Lehmann L
• Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center
  Volume: 25
  03/01/2019 Authors: Schoettler ML; Lehmann LE; Margossian S; Lee M; Kao P-C; Ma C; Duncan C
• Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality
  Volume: 25
  03/01/2019 Authors: Schoettler ML; Lee M; Li A; Ma C; Duncan C
• End Organ Damage Following Refractory/Recurrent Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Pediatric Patients Undergoing Autologous Hematopoietic Cell Transplantation
  Volume: 25
  03/01/2019 Authors: Schoettler ML; Lehmann LE; Margossian S; Li A; Ma C; Duncan C
• Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
  Pediatr Rheumatol Online J Volume: 17 Page(s): 7
  02/14/2019 Authors: Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS
• History of melanoma in situ dyspnea rib pain Dx?
  J Fam Pract Volume: 68 Page(s): E20 - E23
  01/01/2019 Authors: Tong IL; Stump M; Schoettler ML; Bourjeily G
• The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited.
  Hematol Oncol Clin North Am Volume: 32 Page(s): 581 - 594
  08/01/2018 Authors: Schoettler ML; Nathan DG
• Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP ).
  Pediatr Blood Cancer Volume: 64
  05/01/2017 Authors: Schoettler ML; Graham D; Tao W; Stack M; Shu E; Kerr L; Neufeld EJ; Grace RF
• Treatment and outcomes of immune cytopenias following solid organ transplant in children.
  Pediatr Blood Cancer Volume: 62 Page(s): 214 - 218
  02/01/2015 Authors: Schoettler M; Elisofon SA; Kim HB; Blume ED; Rodig N; Boyer D; Neufeld EJ; Grace RF